Sign in

CIK 0001628908

  • Large accelerated filer

Evolent Health, Inc.

Sign in to watch
Ticker
EVH
Exchange
NYSE
Industry
Services-Management Services
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320454912
Phone
+1 571-389-6000
Business address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, VA, 22209
  1. 4 Open-market sale 10% owner sold 2,498,750 shares at $19.53 ($48,800,588)
  2. 4 Open-market sale 10% owner sold 2,690,961 shares at $19.53 ($52,554,468)
  3. 4 Open-market sale President sold 15,000 shares at an average $21.19 ($317,896)
  4. 4 Open-market sale 10% owner sold 2,118,078 shares at $19.53 ($41,366,063)
  5. 4 Open-market sale Chief Financial Officer sold 7,034 shares at $22.50 ($158,265)
  6. 4 Open-market sale President sold 15,000 shares at an average $20.87 ($313,008)
  7. 4 Open-market sale CEO, Valence Health sold 988 shares at $20.20 ($19,958)
  8. 4 Open-market sale Chief Executive Officer sold 16,300 shares at $20.86 ($340,018)
  9. 4 Open-market sale President sold 15,000 shares at an average $20.44 ($306,637)
  10. 4 Open-market sale CEO, Valence Health sold 6,000 shares at $20.11 ($120,660)
  11. 4 Open-market sale CEO, Valence Health sold 12,000 shares at an average $20.13 ($241,500)
  12. 4 Open-market sale Chief Executive Officer sold 32,600 shares at an average $20.15 ($656,727)
  13. 4 Open-market sale President sold 15,000 shares at $19.16 ($287,400)
  14. 4 Open-market sale 10% owner sold 374,812 shares at $21.54 ($8,073,450)
  15. 4 Grant or award Chief Executive Officer acquired 61,644 shares (grant or award)
  16. 4 Grant or award General Counsel acquired 5,479 shares (grant or award)
  17. 4 Grant or award Principal Accounting Officer acquired 2,740 shares (grant or award)
  18. 4 Grant or award Chief Financial Officer acquired 17,123 shares (grant or award)
  19. 4 Grant or award President acquired 41,096 shares (grant or award)
  20. 4 Grant or award Chief Operating Officer acquired 13,699 shares (grant or award)

Page 18 of 22 · 421 filings